Industry Focus

Healthcare: Carl Icahn Fires a Shot at Cigna and Express Scripts’ Planned Tie-Up

Informações:

Sinopsis

Here’s why activist billionaire investor Carl Icahn is telling Cigna shareholders to vote against its purchase of Express Scripts. Also, what Regeneron Pharmaceuticals and bluebird bio's new deal means for investors.